Articles Referencing BSX
The 15 Most Overbought S&P 500 Stocks
5/21/2013, 10:50 am from Minyanville in Investing, Stocks
Stocks continued higher for the fourth week in a row as the
major averages have already easily exceeded the most bullish Wall
Street forecasts for the entire year. All of the major averages... Read >>
Alleged Patent Infringement by BSX - Analyst Blog
5/17/2013, 12:30 pm from Zacks.com in Investing, Business, Stocks
After a series of positive news, medical technology major
Boston Scientific Corporation ( BSX ) received a patent
infringement complaint from Vascular Solutions
Inc. ( VASC ), a... Read >>
Study for STJ's Latest EnligHTN - Analyst Blog
5/15/2013, 9:06 am from Zacks.com in Investing, Business, Stocks
St. Jude Medical Inc. ( STJ ) has initiated the
EnligHTN III trial with the enrollment of the first patient to
evaluate its latest, second-generation EnligHTN Renal Denervation
System in... Read >>
BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector
5/14/2013, 10:03 am from GuruFocus in Investing
In the past week we saw an increase in insider buying coming
from the health care industry. Last week GuruFocus reported 31
different insider buys coming from 19 different health... Read >>
After Hours Most Active for May 13, 2013 : CHK, QQQ, MTU, VONV, TTWO, BAC, LCC, BSX, S, AAPL, FITB, VOD
5/13/2013, 4:44 pm from NASDAQ.com News in News Headlines, After Hours Most Active
The NASDAQ 100
After Hours Indicator is up .36 to 2,982.45. The total After
hours volume is currently 14,657,449 shares traded.
The following are the
most active stocks for the after hours... Read >>
St. Jude's New Quadra Study - Analyst Blog
5/7/2013, 2:23 pm from Zacks.com in Investing, Business, Stocks
St. Jude Medical ( STJ ) has enrolled the
first patient for its MultiPoint Pacing clinical study. The study
will evaluate the efficacy of the company's Quadripolar Pacing
system belonging... Read >>
BSX Beats Y/Y Earnings, Guides Low - Analyst Blog
4/25/2013, 4:12 pm from Zacks.com in Investing, Business, Earnings, Stocks
Boston Scientific ( BSX ) reported adjusted
earnings per share (after considering certain adjustments other
than amortization expense) ("EPS") of 10 cents in the first quarter
of... Read >>
Stryker's 1Q Earnings Beat Est.; Sales Lag - Analyst Blog
4/25/2013, 3:13 pm from Zacks.com in Investing, Business, Earnings, Stocks
Stryker Corporation 's ( SYK ) adjusted earnings
per share (EPS) of $1.03 increased 4.0% year over year in the first
quarter of 2013. It beat the Zacks Consensus Estimate by 2... Read >>
MDT to Grow Endovascular Biz Globally - Analyst Blog
4/8/2013, 3:10 pm from Zacks.com in Investing, Business, Stocks
Medtronic Inc. ( MDT ) has further
strengthened its endovascular portfolio. The company, with the
receipt of CE Mark approval for the Sentrant Introducer Sheath,
will be launching this... Read >>
Boston Scientific Stays at Neutral - Analyst Blog
4/4/2013, 3:10 pm from Zacks.com in Investing, Business, Stocks
We recently reinstated our Neutral recommendation on
Boston Scientific Corporation ( BSX ), a leading
medical devices company. After several quarters of weak
performance, we are encouraged... Read >>
Volcano Strengthens Portfolio - Analyst Blog
3/15/2013, 2:43 pm from Zacks.com in Investing, Business, Stocks
Recently, Volcano Corporation ( VOLC ) launched its
Valet microcatheter in the U.S. and Europe. The company's latest
offering is available in lengths of 100cm, 135cm and 150cm and
sizes... Read >>
BSX's Stent Tops Abbott - Analyst Blog
3/13/2013, 6:14 pm from Zacks.com in Investing, Business, Stocks
Boston Scientific 's ( BSX ) recently released
endpoint data of a clinical trial showed the excellence of the
company's Promus Element Everolimus-Eluting Platinum Chromium
(PtCr) Coronary... Read >>
BSX Reveals Prelim PREVAIL Result - Analyst Blog
3/12/2013, 5:13 pm from Zacks.com in Investing, Business, Stocks
Recently, medical device major - Boston
Scientific ( BSX ) released the
preliminary study result of the PREVAIL clinical trial, which
successfully met 2 out of 3 co-primary endpoints.... Read >>
MDT Submits IDE for Symplicity HTN4 - Analyst Blog
3/8/2013, 12:40 pm from Zacks.com in Investing, Business, Stocks
Leading medical devices player - Medtronic ( MDT ) recently
submitted an Investigational Device Exemption ("IDE") to the US
Food and Drug Administration ("FDA") to study... Read >>
BSX Opts for Full PREVAIL Presentation - Analyst Blog
3/7/2013, 6:29 pm from Zacks.com in Investing, Business, Stocks
Boston Scientific 's ( BSX ) decision earlier
this week to present only the acute procedural safety results of
the PREVAIL clinical trial on the effectiveness of the Watchman
device has... Read >>